DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 12:45:44 28/05/2024 BST | ||
| 0.47 EUR | +4.44% |
|
| Current month | -60.18% | ||
| 1 month | -63.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 0.47 | +4.44% |
| 27/05/24 | 0.45 | -8.16% |
| 24/05/24 | 0.49 | +2.08% |
| 23/05/24 | 0.48 | +11.63% |
| 22/05/24 | 0.43 | +10.26% |
Real-time BOERSE MUENCHEN
Last update May 28, 2024 at 12:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBH |
| ISIN | DE000HD4KBH1 |
| Date issued | 11/04/2024 |
| Strike | 285 $ |
| Maturity | 18/09/2024 (113 Days) |
| Parity | 10 : 1 |
| Emission price | 1.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.37 € |
|---|---|
| Lowest since issue | 0.38 € |
| Spread | 0.04 € |
| Spread % | 7.84% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
